KL, S., KJ, L., M, M., B, B., & P, M. (2021). Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder. Journal of substance abuse treatment, 123, 108263. https://doi.org/10.1016/j.jsat.2020.108263
Chicago Style (17th ed.) CitationKL, Stringer, Langdon KJ, McKenzie M, Brockmann B, and Marotta P. "Leveraging COVID-19 to Sustain Regulatory Flexibility in the Treatment of Opioid Use Disorder." Journal of Substance Abuse Treatment 123 (2021): 108263. https://doi.org/10.1016/j.jsat.2020.108263.
MLA (9th ed.) CitationKL, Stringer, et al. "Leveraging COVID-19 to Sustain Regulatory Flexibility in the Treatment of Opioid Use Disorder." Journal of Substance Abuse Treatment, vol. 123, 2021, p. 108263, https://doi.org/10.1016/j.jsat.2020.108263.